InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the detailed record of transactions filed by Jean-Marie Lefèvre, Chairman of the Board. Insider active across 1 company, notably MAAT PHARMA. In total, 1 reports have been published. Activity tracked since 17 February 2023. The latest transaction was disclosed on 17 February 2023 (Souscription). Regulator: AMF. The full history is openly available.
Companies and markets linked to Jean-Marie Lefèvre
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
250,000 shares@ €8.00100.0% of flowActionEuronext ParisISIN FR00126348222023DD885900
1 of 1 declaration
About Jean-Marie Lefèvre
Jean-Marie Lefèvre is the Chairman of the Board at Maat Pharma. In this role, he oversees the activities of the board and ensures the good governance of the company. His experience in the pharmaceutical sector allows him to guide the company in its strategic decisions and ensure compliance with current regulations. He plays a key role in the future direction of Maat Pharma.
